168 related articles for article (PubMed ID: 32162872)
1. The Performance of Nesfatin-1 in Distinguishing Irritable Bowel Syndrome Presenting Predominantly with Diarrhea from Celiac Disease.
Karatay E; Gül-Utku Ö; Aksoy N
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162872
[TBL] [Abstract][Full Text] [Related]
2. Undiagnosed Celiac Disease In Patients Presenting With Irritable Bowel Syndrome Symptoms.
Khayyat YM
J Ayub Med Coll Abbottabad; 2020; 32(1):18-23. PubMed ID: 32468748
[TBL] [Abstract][Full Text] [Related]
3. New clinical method for distinguishing D-IBS from other gastrointestinal conditions causing diarrhea: the LA/IBS diagnostic strategy.
Pimentel M; Hwang L; Melmed GY; Low K; Vasiliauskas E; Ippoliti A; Yang J; Lezcano S; Conklin JL; Sahakian A
Dig Dis Sci; 2010 Jan; 55(1):145-9. PubMed ID: 19169820
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.
Pimentel M; Morales W; Rezaie A; Marsh E; Lembo A; Mirocha J; Leffler DA; Marsh Z; Weitsman S; Chua KS; Barlow GM; Bortey E; Forbes W; Yu A; Chang C
PLoS One; 2015; 10(5):e0126438. PubMed ID: 25970536
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of coeliac disease in patients fulfilling Rome III criteria for irritable bowel syndrome.
Shalaby SA; Sayed MM; Ibrahim WA; Abdelhakam SM; Rushdy M
Arab J Gastroenterol; 2016 Jun; 17(2):73-7. PubMed ID: 27349575
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.
Rezaie A; Park SC; Morales W; Marsh E; Lembo A; Kim JH; Weitsman S; Chua KS; Barlow GM; Pimentel M
Dig Dis Sci; 2017 Jun; 62(6):1480-1485. PubMed ID: 28451914
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study.
Linsalata M; Riezzo G; D'Attoma B; Clemente C; Orlando A; Russo F
BMC Gastroenterol; 2018 Nov; 18(1):167. PubMed ID: 30400824
[TBL] [Abstract][Full Text] [Related]
8. Sucrase-Isomaltase Deficiency as a Potential Masquerader in Irritable Bowel Syndrome.
Kim SB; Calmet FH; Garrido J; Garcia-Buitrago MT; Moshiree B
Dig Dis Sci; 2020 Feb; 65(2):534-540. PubMed ID: 31493040
[TBL] [Abstract][Full Text] [Related]
9. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
[TBL] [Abstract][Full Text] [Related]
10. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
[TBL] [Abstract][Full Text] [Related]
11. Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.
Choghakhori R; Abbasnezhad A; Amani R; Alipour M
Dig Dis Sci; 2017 Jun; 62(6):1550-1560. PubMed ID: 28374085
[TBL] [Abstract][Full Text] [Related]
12. Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndrome.
Barmeyer C; Schumann M; Meyer T; Zielinski C; Zuberbier T; Siegmund B; Schulzke JD; Daum S; Ullrich R
Int J Colorectal Dis; 2017 Jan; 32(1):29-39. PubMed ID: 27695975
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of celiac disease in Iranian patients with irritable bowel syndrome: a cross-sectional study.
Shayesteh AA; Hajiani E; Hashemi SJ; Masjedizadeh A; Latifi SM; Shayesteh M
J Dig Dis; 2014 Jan; 15(1):12-7. PubMed ID: 24320042
[TBL] [Abstract][Full Text] [Related]
14. Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome: Validation of Symptom Frequency Questionnaire.
Azpiroz F; Guyonnet D; Donazzolo Y; Gendre D; Tanguy J; Guarner F
J Clin Gastroenterol; 2015 Aug; 49(7):e64-70. PubMed ID: 25014236
[TBL] [Abstract][Full Text] [Related]
15. Celiac Disease in Patients Fulfilling the Rome III Criteria for Irritable Bowel Syndrome Attending Gastroenterology Department of A Tertiary Care Hospital in Bangladesh.
Chowdhury MK; Chakraborty R; Gope S; Rahman MA; Miah AR; Raihan AS; Sarkar S; Paul BK; Ferdousi KR
Mymensingh Med J; 2016 Jan; 25(1):102-8. PubMed ID: 26931258
[TBL] [Abstract][Full Text] [Related]
16. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.
Hod K; Ringel-Kulka T; Martin CF; Maharshak N; Ringel Y
J Clin Gastroenterol; 2016 Mar; 50(3):227-32. PubMed ID: 25930973
[TBL] [Abstract][Full Text] [Related]
17. Pro-inflammatory and anti-inflammatory cytokine response in diarrhoea-predominant irritable bowel syndrome patients.
Rana SV; Sharma S; Sinha SK; Parsad KK; Malik A; Singh K
Trop Gastroenterol; 2012; 33(4):251-6. PubMed ID: 23923350
[TBL] [Abstract][Full Text] [Related]
18. [Irritable bowel syndrome, celiac disease and gluten].
Mearin F; Montoro M
Med Clin (Barc); 2014 Aug; 143(3):124-9. PubMed ID: 24029448
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A case-control study.
Sánchez-Vargas LA; Thomas-Dupont P; Torres-Aguilera M; Azamar-Jacome AA; Ramírez-Ceervanes KL; Aedo-Garcés MR; Meixueiro-Daza A; Roesch-Dietlen F; Grube-Pagola P; Vivanco-Cid H; Remes-Troche JM
Neurogastroenterol Motil; 2016 Jul; 28(7):994-1000. PubMed ID: 26914655
[TBL] [Abstract][Full Text] [Related]
20. Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.
Singh P; Silvester J; Chen X; Xu H; Sawhney V; Rangan V; Iturrino J; Nee J; Duerksen DR; Lembo A
United European Gastroenterol J; 2019 Jun; 7(5):709-715. PubMed ID: 31210949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
